Cargando…
Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis
Adjuvant chemotherapy is recommended for postoperative stage II-IIIB nonsmall cell lung cancer patients. However, its effect remains controversial in stage IB patients. We, therefore, performed a meta-analysis to compare the efficacy of adjuvant chemotherapy versus surgery alone in stage IB patients...
Autores principales: | He, Jiaxi, Shen, Jianfei, Yang, Chenglin, Jiang, Long, Liang, Wenhua, Shi, Xiaoshun, Xu, Xin, He, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616365/ https://www.ncbi.nlm.nih.gov/pubmed/26039122 http://dx.doi.org/10.1097/MD.0000000000000903 |
Ejemplares similares
-
The Tumor-immune Index is Correlated With the Prognosis of Patients After Curative Resection for Nonsmall Cell Lung Cancer
por: Li, Bobo, et al.
Publicado: (2015) -
Two-portal versus three-port video-assist thoracoscopic surgery for early stage nonsmall cell lung cancer: A retrospective study
por: Yan, Xiaokun, et al.
Publicado: (2017) -
Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer
por: Wang, Bing-Yen, et al.
Publicado: (2016) -
Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer
por: Bao, Huizheng, et al.
Publicado: (2017) -
Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)